Literature DB >> 22114073

Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.

Vijay S Thakur1, Karishma Gupta, Sanjay Gupta.   

Abstract

Green tea polyphenols (GTPs) reactivate epigenetically silenced genes in cancer cells and trigger cell cycle arrest and apoptosis; however, the mechanisms whereby these effects occur are not well understood. We investigated the molecular mechanisms underlying the antiproliferative effects of GTP, which may be similar to those of histone deacetylase (HDAC) inhibitors. Exposure of human prostate cancer LNCaP cells (harboring wild-type p53) and PC-3 cells (lacking p53) with 10-80 μg/ml of GTP for 24 h resulted in dose-dependent inhibition of class I HDAC enzyme activity and its protein expression. GTP treatment causes an accumulation of acetylated histone H3 in total cellular chromatin, resulting in increased accessibility to bind with the promoter sequences of p21/waf1 and Bax, consistent with the effects elicited by an HDAC inhibitor, trichostatin A. GTP treatment also resulted in increased expression of p21/waf1 and Bax at the protein and message levels in these cells. Furthermore, treatment of cells with proteasome inhibitor, MG132 together with GTP prevented degradation of class I HDACs, compared with cells treated with GTP alone, indicating increased proteasomal degradation of class I HDACs by GTP. These alterations were consistent with G(0)-G(1) phase cell cycle arrest and induction of apoptosis in both cell lines. Our findings provide new insight into the mechanisms of GTP action in human prostate cancer cells irrespective of their p53 status and suggest a novel approach to prevention and/or therapy of prostate cancer achieved via HDAC inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114073      PMCID: PMC3499108          DOI: 10.1093/carcin/bgr277

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  42 in total

1.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Authors:  V M Richon; Y Webb; R Merger; T Sheppard; B Jursic; L Ngo; F Civoli; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 2.  Clinical development of histone deacetylase inhibitors as anticancer agents.

Authors:  Daryl C Drummond; Charles O Noble; Dmitri B Kirpotin; Zexiong Guo; Gary K Scott; Christopher C Benz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

3.  Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.

Authors:  Lin Gao; Maria A Cueto; Fred Asselbergs; Peter Atadja
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

4.  Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Authors:  L M Butler; D B Agus; H I Scher; B Higgins; A Rose; C Cordon-Cardo; H T Thaler; R A Rifkind; P A Marks; V M Richon
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

5.  Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.

Authors:  Wilko Weichert; Annika Röske; Silvia Niesporek; Aurelia Noske; Ann-Christin Buckendahl; Manfred Dietel; Volker Gekeler; Markus Boehm; Thomas Beckers; Carsten Denkert
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

6.  Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.

Authors:  Kedar Hastak; Sanjay Gupta; Nihal Ahmad; Mukesh K Agarwal; Munna L Agarwal; Hasan Mukhtar
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

7.  Expression profile of class I histone deacetylases in human cancer tissues.

Authors:  Masamune Nakagawa; Yoshinao Oda; Takashi Eguchi; Shin-Ichi Aishima; Takashi Yao; Fumihito Hosoi; Yuji Basaki; Mayumi Ono; Michihiko Kuwano; Masao Tanaka; Masazumi Tsuneyoshi
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

Review 8.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.

Authors:  Yongming Li; Xia Li; Bin Guo
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

10.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.

Authors:  W Weichert; A Röske; V Gekeler; T Beckers; C Stephan; K Jung; F R Fritzsche; S Niesporek; C Denkert; M Dietel; G Kristiansen
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  40 in total

1.  Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.

Authors:  Prerna Kumar; Satyabha Tripathi; Kailash N Pandey
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

Review 2.  Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Naghma Khan; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 3.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

4.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

Review 5.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

6.  Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.

Authors:  Tripti Singh; Ram Prasad; Santosh K Katiyar
Journal:  Epigenetics       Date:  2012-12-05       Impact factor: 4.528

Review 7.  Modulation of signaling pathways in prostate cancer by green tea polyphenols.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2012-10-03       Impact factor: 5.858

Review 8.  Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer.

Authors:  Tasnima Khushnud; Shaker A Mousa
Journal:  Mol Biotechnol       Date:  2013-09       Impact factor: 2.695

Review 9.  Manipulating the epigenome for the treatment of urological malignancies.

Authors:  Colm J O'Rourke; Vinicius Knabben; Eva Bolton; Diarmaid Moran; Thomas Lynch; Donal Hollywood; Antoinette S Perry
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

10.  Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.

Authors:  Rajnee Kanwal; Mitali Pandey; Natarajan Bhaskaran; Gregory T Maclennan; Pingfu Fu; Lee E Ponsky; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2012-07-25       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.